Join Crystal Pharmatech at 16th American DDF Summit, from September 14–15, 2026, in Boston, MA.
As a technology-driven CRO/CDMO, we invite you to discover how our "First-Time-Right" approach delivers strategic, phase-appropriate solutions that de-risk drug development and accelerate your development of new medicines.
What you will take away from Crystal Pharmatech:
Our experts will lead in-depth discussions on how our specialized platforms can de-risk your 2026 development goals:
Small Molecule: Solid-State Research, Preformulation, and CMC Formulation Development through to GMP Manufacturing (First-Time-Right approach).
Nucleic Acids (Crystal NAX): Focused on nucleic acid therapeutics, integrating LNP formulation, analytical science, and process development for mRNA, siRNA, and oligonucleotide programs.
Co-founder and CBO
Crystal Pharmatech
Subject Matter Expert
Crystal Pharmatech
CEO of Canada CDMO BU
Candoo Pharmatech
Senior Business Development Manager
Crystal NAX
When: September 14-15, 2026
Where: Omni Boston Hotel at the Seaport, Boston, MA
Subscribe to be the first to get the updates!
